Canterbury Park Holding Azioni (NASDAQ: CPHC)

Ultime notizie per Canterbury Park Holding (NASDAQ:CPHC) Azioni

Canterbury Park Holding

Canterbury Park Holding Corp is in the business of pari-mutuel wagering on horse races and unbanked card games at its canterbury park racetrack and card casino facility in Minnesota. The company has four operating segments. The horse racing segment represents pari-mutuel wagering operations on simulcast and lives horse races; the Casino segment represents unbanked card operations; the food and beverage segment includes concessions, catering, and events services provided at the Racetrack; and the development segment represents its real estate development operations. The firm generates a majority of its revenue from the Casino segment.

Canterbury Park Holding Corporation - Common Stock

Canterbury Park Holding Corp

Earnings

News

CPHC

Canterbury Park Holding Q3 2024 Net Revenue $19.3M Vs $19.27M YoY; EPS $0.40 Vs $0.23 YoY

Canterbury Park Holding Corporation&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cphc#NASDAQ">CPHC</a>) posted mixed financial results for the second quarter of 2024, reflecting steady operational performance alongside significant non-recurring factors that heavily impacted the bottom line. Despite a sharp decline in earnings per share, the company managed to maintain stability in key areas, showcasing resilient core operations. This quarter&#39;s results highlight Canterbury Park&#39;s strategic focus on optimizing its business segments, managing expenses, and advancing its real estate development projects, all while navigating a challenging environment.
<div class="chart_embed">
<h3>Canterbury Park Holding Corporation Price, Consensus and EPS Surprise</h3>
<img alt="Canterbury Park Holding Corporation Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/db/1723206267.png" style="height:265px; width:538px" title="" />
Canterbury Park Holding Corporation price-consensus-eps-surprise-chart | Canterbury Park Holding Corporation Quote
Here&#39;s a closer look at the factors influencing Canterbury Park&#39;s latest earnings report.
</div>
<h3>Q2 Results</h3>
Canterbury Park reported second-quarter 2024 earnings per diluted share of 7 cents, declining 93.5% from the $1.07 reported in the year-ago quarter.
Total quarterly revenues of $16.2 million declined slightly by 0.9% from $16.3 million reported in the prior-year quarter.
The weak quarterly earnings were mainly driven by a reduction in Casino revenues, which was a result of ongoing efforts to optimize the company&#39;s marketing reinvestment program, aimed at maintaining consistent visitation from high-end players while limiting short-term. The negatives were partially offset by revenue growth in the Pari-mutuel, Food and Beverage, and Other segments due to additional live race days and improved performance in event hosting.
<h3>Segment Performance</h3>
Casino:&nbsp;The Casino segment, Canterbury Park&#39;s largest revenue contributor, witnessed a 5.2% decline in revenues, decreasing to $9.8 million from $10.4 million in the second quarter of 2023. The decrease was primarily due to the lower table games drop, reflecting the company&#39;s strategic focus on optimizing marketing efforts and targeting high-end players for more consistent visitation.
Pari-mutuel:&nbsp;Pari-mutuel revenues increased 5.2% year over year, reaching $2.6 million compared with $2.5 million in the second quarter of 2023. Growth was supported by two additional live race days and a higher out-of-state handle, driven by increased field sizes, which contributed to the segment&#39;s positive performance.
Food &amp; Beverage:&nbsp;The Food &amp; Beverage segment generated $2.1 million in revenues, marking a 3.6% increase from $2 million in the prior-year quarter. This growth was attributed to enhanced catering operations and higher admissions revenues bolstered by the hosting of large-scale special events.
Other Revenue:&nbsp;Other revenue, which includes income from events and non-core activities, rose 13.6% to $1.7 million from $1.5 million in the second quarter of 2023. This significant growth was driven by the company&#39;s efforts to position its event center as a premier destination for events of all sizes, benefiting from increased utilization.
<h3>Expenses</h3>
The company managed to reduce operating expenses by 1.3% to $15.1 million, down from $15.3 million in the prior year. This decline was primarily due to lower advertising, marketing, and other operating expenses. However, these savings were partly offset by increased purse expenses and depreciation costs. The reduction in expenses helped mitigate the impact of lower revenues on profitability.
<h3>Net Income and Adjusted EBITDA</h3>
Net income for second-quarter 2024 plunged 93.6% to $0.34 million from $5.3 million in the second quarter of 2023. This drastic decline is largely due to the absence of a $6.5 million gain on the sale of land in the second quarter of 2023, which did not recur this year.
Adjusted EBITDA, however, showed stability, increasing slightly by 1% to $2.4 million from $2.38 million reported in the second quarter of 2023, indicating consistent operational efficiency.
Excluding such non-recurring items, Canterbury Park&#39;s core business operations remained robust, as evidenced by the stable adjusted EBITDA margin, which improved to 14.9% from 14.6% in the prior-year quarter.
<h3>Cash &amp; Debt</h3>
The company&#39;s balance sheet remains strong, with unrestricted cash and short-term investments totaling nearly $24 million. Importantly, Canterbury Park has managed to fund its growth initiatives without incurring debt, allowing it to maintain financial flexibility while returning capital to shareholders through its quarterly cash dividend.
<h3>Other Developments</h3>
Canterbury Park continues to make significant strides in its real estate development projects, particularly the Canterbury Commons. The Swervo Development Corporation&#39;s amphitheater remains on track for a Summer 2025 opening, and the construction of a new 10,000-square-foot commercial building within the Winners Circle development is nearing completion. Additionally, Greystone&#39;s progress on a second commercial office building signals further development activity, which could enhance the value of Canterbury Park&#39;s real estate portfolio.
Moreover, the company is working on the relocation and redevelopment of its barns, with completion expected by early 2025. The continued leasing activity in residential projects, such as the Triple Crown Residences and The Omry, indicates strong demand in the housing market surrounding Canterbury Park&#39;s developments.
These ongoing developments underscore Canterbury Park&#39;s long-term vision of transforming Canterbury Commons into a regional destination, which could drive new revenue sources and economic growth for the company. However, the financial impact of these projects will likely unfold over the next few years, requiring sustained execution and capital investment.
<a href="https://www.zacks.com/stock/news/2320244/canterbury-park-cphc-q2-earnings-revenues-decline-y-y?cid=CS-BENZ-FT-analyst_blog|earnings_article-2320244">To read this article on Zacks.com click here.</a>

Dividends

Small Cap

Markets

Trading Ideas

Canterbury Park Q2 Earnings & Revenues Decline Y/Y

Canterbury Park Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPHC#NASDAQ">CPHC</a>) reported quarterly earnings of $0.07 per share. This is a 93.46 percent decrease over earnings of $1.07 per share from the same period last year. The company reported $16.20 million in sales this quarter. This is a 0.86 percent decrease over sales of $16.34 million the same period last year.

Canterbury Park Holding Q2 EPS $0.07 Down From $1.07 YoY, Sales $16.20M Down From $16.34M YoY

Canterbury Park Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPHC#NASDAQ">CPHC</a>) reported quarterly earnings of $0.20 per share. This is a 64.29 percent decrease over earnings of $0.56 per share from the same period last year. The company reported $14.10 million in sales this quarter. This is a 6.00 percent increase over sales of $13.30 million the same period last year.

Canterbury Park Holding Q1 EPS $0.20 Down From $0.56 YoY, Sales $14.10M Up From $13.30M YoY

WIIM

Canterbury Park Holding shares are trading higher in possible sympathy with MGM.

<h3>Gainers</h3>
<ul>
<li>Carvana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) stock increased by 30.8% to $113.95 during Thursday's regular session. The market value of their outstanding shares is at $13.2 billion. The company's, Q1 earnings came out yesterday. </li>
<li>Cazoo Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CZOO#NYSE">CZOO</a>) stock rose 29.03% to $10.79. The market value of their outstanding shares is at $52.7 million. </li>
<li>Perdoceo Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRDO#NASDAQ">PRDO</a>) stock increased by 27.64% to $23.41. The company's market cap stands at $1.5 billion. The company's, Q1 earnings came out yesterday. </li>
<li>Rush Street Interactive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSI#NYSE">RSI</a>) shares increased by 18.69% to $7.62. The market value of their outstanding shares is at $606.1 million. The company's, Q1 earnings came out yesterday. </li>
<li>Vroom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRM#NASDAQ">VRM</a>) shares increased by 15.47% to $13.26. The company's market cap stands at $23.7 million. </li>
<li>Canterbury Park Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPHC#NASDAQ">CPHC</a>) stock rose 15.21% to $26.5. The market value of their outstanding shares is at $132.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>XPEL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XPEL#NASDAQ">XPEL</a>) shares decreased by 31.2% to $37.0 during Thursday's regular session. The market value of their outstanding shares is at $1.0 billion. As per the press release, Q1 earnings came out today. </li>
<li>Etsy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETSY#NASDAQ">ETSY</a>) shares declined by 14.63% to $59.54. The company's market cap stands at $6.9 billion. As per the news, the Q1 earnings report came out yesterday. </li>
<li>DoorDash (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NASDAQ">DASH</a>) shares decreased by 12.13% to $112.01. The market value of their outstanding shares is at $45.8 billion. As per the press release, Q1 earnings came out yesterday. </li>
<li>Fenbo Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEBO#NASDAQ">FEBO</a>) stock declined by 11.92% to $12.35. The company's market cap stands at $136.6 million. </li>
<li>Faraday Future (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIE#NASDAQ">FFIE</a>) stock decreased by 11.28% to $0.04. The company's market cap stands at $1.7 million. </li>
<li>17 Education &amp; Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YQ#NASDAQ">YQ</a>) stock declined by 11.07% to $2.33. The market value of their outstanding shares is at $18.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

CVNA

CZOO

DASH

ETSY

FEBO

FFIE

PRDO

XPEL

12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>U Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCAR#NASDAQ">UCAR</a>) stock moved upwards by 57.6% to $7.41 during Monday's pre-market session. The market value of their outstanding shares is at $18.2 million. </li>
<li>Jiuzi Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JZXN#NASDAQ">JZXN</a>) stock increased by 13.33% to $0.7. The company's market cap stands at $82.7 million. </li>
<li>Selina Hospitality (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNA#NASDAQ">SLNA</a>) shares moved upwards by 12.7% to $0.06. The company's market cap stands at $18.7 million. </li>
<li>Mondee Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOND#NASDAQ">MOND</a>) stock rose 11.96% to $2.34. The market value of their outstanding shares is at $195.5 million. </li>
<li>Canterbury Park Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPHC#NASDAQ">CPHC</a>) shares rose 11.86% to $26.5. The market value of their outstanding shares is at $131.7 million. </li>
<li>Worksport (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKSP#NASDAQ">WKSP</a>) shares moved upwards by 9.83% to $0.67. The market value of their outstanding shares is at $16.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Allurion Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALUR#NYSE">ALUR</a>) stock declined by 12.3% to $2.13 during Monday's pre-market session. The market value of their outstanding shares is at $101.9 million. </li>
<li>Color Star Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADD#NASDAQ">ADD</a>) shares fell 10.0% to $0.19. The company's market cap stands at $4.2 million. </li>
<li>Volcon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VLCN#NASDAQ">VLCN</a>) stock declined by 4.97% to $0.31. The company's market cap stands at $5.8 million. </li>
<li>Connexa Sports Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXA#NASDAQ">CNXA</a>) stock fell 4.94% to $0.28. The company's market cap stands at $52.6 million. </li>
<li>ZHONGCHAO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCMD#NASDAQ">ZCMD</a>) shares declined by 4.77% to $2.0. The market value of their outstanding shares is at $4.9 million. </li>
<li>Massimo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAMO#NASDAQ">MAMO</a>) stock fell 4.61% to $3.73. The company's market cap stands at $154.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALUR

CONNEXA SPORTS TECH INC by Connexa Sports Technologies Inc.

CNXA

JZXN

MAMO

MOND

SLNA

UCAR

VLCN

WKSP

ZCMD

12 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session

Canterbury Park Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPHC#NASDAQ">CPHC</a>) reported quarterly earnings of $0.27 per share. This is a 22.73 percent increase over earnings of $0.22 per share from the same period last year. The company reported $12.53 million in sales this quarter. This is a 4.51 percent decrease over sales of $13.12 million the same period last year.

Canterbury Park Holding Q4 EPS $0.27 Up From $0.22 YoY, Sales $12.53M Down From $13.12M YoY

<h3>What are Value Stocks?</h3>
A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued. 
<h2>Below is a list of notable value stocks in the consumer cyclical sector:</h2>
<ol>
<li>Weyco Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WEYS#NASDAQ">WEYS</a>) - P/E: 9.41</li>
<li>Toll Brothers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOL#NYSE">TOL</a>) - P/E: 8.32</li>
<li>Destination XL Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXLG#NASDAQ">DXLG</a>) - P/E: 9.17</li>
<li>Dillard's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDS#NYSE">DDS</a>) - P/E: 8.75</li>
<li>Canterbury Park Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPHC#NASDAQ">CPHC</a>) - P/E: 9.82</li>
</ol>
Weyco Group saw an increase in earnings per share from 0.5 in Q2 to $0.98 now. The company's most recent dividend yield sits at 3.82%, which has increased by 0.16% from 3.66% last quarter. 
Toll Brothers has reported Q4 earnings per share at $4.11, which has increased by 10.19% compared to Q3, which was 3.73. Most recently, the company reported a dividend yield of 0.91%, which has decreased by 0.17% from last quarter's yield of 1.08%.
Destination XL Group's earnings per share for Q3 sits at $0.07, whereas in Q2, they were at 0.23. Most recently, Dillard's reported earnings per share at $9.3, whereas in Q2 earnings per share sat at $7.98. Most recently, Canterbury Park Holding reported earnings per share at $0.23, whereas in Q2 earnings per share sat at $1.07. The company's most recent dividend yield sits at 1.96%, which has increased by 0.52% from 1.44% last quarter. 
These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.

DXLG

WEYS

A Look Into Consumer Cyclical Sector Value Stocks

Shares of Amtech Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asys#NASDAQ">ASYS</a>) shares fell sharply during Thursday&rsquo;s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales guidance below estimates.
Amtech reported quarterly sales of $27.70 million, missing the analyst consensus estimate of $34.50 million. The company anticipated first-quarter revenue to be between $21 million and $24 million, versus the $34.15 million estimate.
Benchmark analyst Mark Miller downgraded Amtech Systems from Buy to Hold.
Amtech Systems shares fell 30.6% to $4.16 on Thursday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Freight Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/frgt#NASDAQ">FRGT</a>) shares jumped 322% to $1.14 after the company announced Amazon Mexico renewed its selection of Fr8App for its logistical solutions.</li>
<li>SRIVARU Holding Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/svmh#NASDAQ">SVMH</a>) rose 74.8% to $0.7000.</li>
<li>XBP Europe Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xbp#NASDAQ">XBP</a>) shares gained 49% to $8.46 after declining around 20% on Wednesday.</li>
<li>TPI Composites, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tpic#NASDAQ">TPIC</a>) rose 46% to $3.1350 as the company announced refinancing transaction with Oaktree, significantly strengthening company&rsquo;s liquidity position and enhancing financial flexibility.</li>
<li>Nxu, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxu#NASDAQ">NXU</a>) rose 43.6% to $0.0280 after the company signed a letter of intent outlining investment in Lynx Motors.</li>
<li>Canterbury Park Holding Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cphc#NASDAQ">CPHC</a>) rose 31% to $18.70.</li>
<li>View, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/view#NASDAQ">VIEW</a>) gained 29% to $5.14.</li>
<li>Hanryu Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hryu#NASDAQ">HRYU</a>) gained 27.1% to $1.3850 after jumping 28% on Wednesday.</li>
<li>Esperion Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/espr#NASDAQ">ESPR</a>) shares climbed 23.2% to $1.8603. Esperion said that the FDA updated LDL-C lowering indication for NEXLETOL (bempedoic acid) tablet and NEXLIZET (bempedoic acid and ezetimibe) tablet.</li>
<li>Redfin Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdfn#NASDAQ">RDFN</a>) gained 21.8% to $10.26.</li>
<li>Codexis, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdxs#NASDAQ">CDXS</a>) shares surged 20.5% to $2.5184. Codexis announced achievement of gram-scale synthesis with its ECO Synthesis platform.</li>
<li>Vista Gold Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vgz#NYSE">VGZ</a>) gained 20% to $0.4010. Vista Gold announced a $20 million royalty with Wheaton Precious Metals Corp. on Mt Todd.</li>
<li>Altice USA, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/atus#NYSE">ATUS</a>) rose 18.8% to $2.4950.</li>
<li>Sunnova Energy International Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nova#NYSE">NOVA</a>) gained 18.3% to $14.09.</li>
<li>Wayfair Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/w#NYSE">W</a>) rose 17.3% to $66.75.</li>
<li>Sunrun Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/run#NASDAQ">RUN</a>) gained 16.7% to $17.42.</li>
<li>Blend Labs, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/blnd#NYSE">BLND</a>) surged 16.7% to $2.1950. Blend Labs Head of Finance and Admin. Amir Jafari acquired a total of 12,610 shares at an average price of $1.22.</li>
<li>Moderna, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrna#NASDAQ">MRNA</a>) rose 15.8% to $91.14. Moderna and Merck &amp; Co announced follow-up data from the Phase 2b randomized KEYNOTE-942/mRNA-4157-P201 study of mRNA-4157 (V940), an investigational individualized neoantigen therapy (INT), in combination with Keytruda in patients with resected high-risk melanoma (stage III/IV) following complete resection.</li>
<li>VCI Global Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vcig#NASDAQ">VCIG</a>) gained 15.4% to $2.62 after its financial technology arm, Accuventures Sdn Bhd, agreed to acquire the Malaysian digital platform EVOLET.</li>
<li>Pacific Biosciences of California, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pacb#NASDAQ">PACB</a>) surged 14.2% to $10.12. Stephens &amp; Co. initiated coverage on Pacific Biosciences with an Overweight rating and announced a price target of $11.</li>
<li>Alector, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alec#NASDAQ">ALEC</a>) rose 14.8% to $7.92. Stifel upgraded Alector from Hold to Buy and raised the price target from $8 to $15.</li>
<li>Opendoor Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/open#NASDAQ">OPEN</a>) gained 14.4% to $4.71.</li>
<li>Enphase Energy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/enph#NASDAQ">ENPH</a>) rose 13.6% to $122.22.</li>
<li>Plug Power Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plug#NASDAQ">PLUG</a>) gained 12.7% to $4.8550.</li>
<li>Alcoa Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aa#NYSE">AA</a>) gained 11% to $28.84. Alcoa received approval for continued mining in Western Australia.</li>
<li>RH (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rh#NYSE">RH</a>) gained 7.3% to $304.60.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Reneo Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rphm#NASDAQ">RPHM</a>) shares dipped 87.3% to $0.9861. Reneo Pharmaceuticals said its pivotal STRIDE study of mavodelpar in adult patients with primary mitochondrial myopathies did not meet its primary efficacy or secondary efficacy endpoint.</li>
<li>Mynd.ai, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mynd#NYSE">MYND</a>) fell 53.1% to $2.71.</li>
<li>Cepton, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cptn#NASDAQ">CPTN</a>) fell 24.2% to $3.01 after the company posted downbeat third-quarter sales and issued weak FY23 revenue forecast. Craig-Hallum downgraded Cepton from Buy to Hold.</li>
<li>Apellis Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apls#NASDAQ">APLS</a>) declined 20.7% to $49.81 after the company announced it was informed of a negative trend vote on the marketing authorization application for pegcetacoplan.</li>
<li>NextCure, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxtc#NASDAQ">NXTC</a>) fell 20.7% to $1.15 after the company issued year-end clinical pipeline updates.</li>
<li>MIND Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mind#NASDAQ">MIND</a>) dipped 19.4% to $4.7414 following weak quarterly results.</li>
<li>Aditxt, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adtx#NASDAQ">ADTX</a>) fell 16.4% to $5.26.</li>
<li>Ocular Therapeutix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocul#NASDAQ">OCUL</a>) shares fell 15.1% to $3.3450. Ocular Therapeutix priced its public offering of 30.8 million common share stock at $3.25 per share for gross proceeds of $100.1 million.</li>
<li>NextPlay Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxtp#NASDAQ">NXTP</a>) shares fell 11.4% to $1.3905 after jumping 68% on Wednesday.</li>
<li>Regis Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rgs#NYSE">RGS</a>) shares fell 9.9% to $8.39. NYSE will begin delisting proceedings against Regis Corp.</li>
<li>ABM Industries Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/abm#NYSE">ABM</a>) dipped 9.5% to $47.33. ABM recently reported better-than-expected fourth-quarter financial results and issued guidance.</li>
<li>Intensity Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ints#NASDAQ">INTS</a>) shares fell 9.4% to $8.94 after jumping 22% on Wednesday. Intensity Therapeutics recently named Joseph Talamo as CFO.</li>
<li>AerSale Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asle#NASDAQ">ASLE</a>) shares fell 8% to $13.60. AerSale priced its secondary offering of 4 million common shares.</li>
<li>B. Riley Financial, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rily#NASDAQ">RILY</a>) fell 7.6% to $19.95.</li>
<li>Adobe Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adbe#NASDAQ">ADBE</a>) fell 6.2% to $585.55. Adobe posted upbeat earnings for its fourth quarter, but issued weak sales forecast for full-year 2024.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/12/36231379/wait-for-a-pullback-youre-late-to-the-party-jim-cramer-says-about-this-tech-stock"> &#39;Wait For A Pullback &mdash; You&#39;re Late To The Party&#39;: Jim Cramer Says About This Tech Stock</a>

Penny Stocks

Intraday Update

ADBE

ADTX

ALEC

APLS

ASLE

ASYS

ATUS

BLND

CDXS

CPTN

ENPH

ESPR

FRGT

HRYU

INTS

MIND

MRNA

MYND

NOVA

NXTC

NXTP

OCUL

OPEN

PACB

PLUG

RDFN

RILY

RPHM

SVMH

TPIC

VCIG

VIEW

Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>Canterbury Park Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPHC#NASDAQ">CPHC</a>) shares increased by 32.4% to $18.9 during Thursday's regular session. The company's market cap stands at $93.4 million. </li>
<li>Gaotu Techedu (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOTU#NYSE">GOTU</a>) shares moved upwards by 23.44% to $4.55. The market value of their outstanding shares is at $1.1 billion. </li>
<li>Esports Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMBL#NASDAQ">GMBL</a>) shares moved upwards by 20.78% to $0.02. The market value of their outstanding shares is at $9.1 million. </li>
<li>Color Star Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADD#NASDAQ">ADD</a>) shares rose 17.62% to $0.34. The company's market cap stands at $7.6 million. </li>
<li>Carvana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) shares rose 16.81% to $52.65. The company's market cap stands at $6.0 billion. </li>
<li>BowFlex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFX#NYSE">BFX</a>) shares moved upwards by 16.7% to $0.63. The market value of their outstanding shares is at $22.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Mynd.ai (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MYND#AMEX">MYND</a>) stock fell 26.5% to $4.25 during Thursday's regular session. </li>
<li>Vision Marine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMAR#NASDAQ">VMAR</a>) shares declined by 15.33% to $1.16. The company's market cap stands at $13.5 million. </li>
<li>Jowell Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JWEL#NASDAQ">JWEL</a>) shares declined by 13.52% to $2.18. The company's market cap stands at $4.6 million. </li>
<li>Regis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGS#NYSE">RGS</a>) stock declined by 12.95% to $8.11. The market value of their outstanding shares is at $18.4 million. </li>
<li>BT Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTBD#NASDAQ">BTBD</a>) shares decreased by 11.18% to $1.67. The company's market cap stands at $10.4 million. </li>
<li>Lanvin Group Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LANV#NYSE">LANV</a>) shares declined by 10.78% to $3.44. The company's market cap stands at $402.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BTBD

GMBL

GSX Techedu Inc. American Depositary Shares

GOTU

JWEL

LANV

VMAR

Canterbury Park Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPHC#NASDAQ">CPHC</a>) reported quarterly earnings of $0.23 per share. This is a 61.67 percent decrease over earnings of $0.60 per share from the same period last year. The company reported $19.27 million in sales this quarter. This is a 13.56 percent decrease over sales of $22.29 million the same period last year.

Canterbury Park Holding Q3 EPS $0.23 Down From $0.60 YoY, Sales $19.27M Down From $22.29M YoY

<h3>What is a Value Stock?</h3>
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock. 
<h2>Benzinga Insights has compiled a list of value stocks in the consumer cyclical sector that may be worth watching:</h2>
<ol>
<li>International Paper (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IP#NYSE">IP</a>) - P/E: 8.71</li>
<li>General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) - P/E: 4.68</li>
<li>Express (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXPR#NYSE">EXPR</a>) - P/E: 0.14</li>
<li>Weyco Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WEYS#NASDAQ">WEYS</a>) - P/E: 7.72</li>
<li>Canterbury Park Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPHC#NASDAQ">CPHC</a>) - P/E: 8.74</li>
</ol>
International Paper saw an increase in earnings per share from 0.53 in Q1 to $0.59 now. The company's most recent dividend yield sits at 5.93%, which has increased by 0.22% from 5.71% last quarter. 
This quarter, General Motors experienced a decrease in earnings per share, which was $2.21 in Q1 and is now $1.91. Its most recent dividend yield is at 0.93%, which has decreased by 0.14% from 1.07% in the previous quarter.
Most recently, Express reported earnings per share at $-19.8, whereas in Q4 earnings per share sat at $-12.6. Most recently, Weyco Group reported earnings per share at $0.5, whereas in Q1 earnings per share sat at $0.78. Most recently, the company reported a dividend yield of 3.66%, which has decreased by 0.11% from last quarter's yield of 3.77%.
Canterbury Park Holding saw an increase in earnings per share from 0.56 in Q1 to $1.07 now. Its most recent dividend yield is at 1.18%, which has increased by 0.08% from 1.1% in the previous quarter.
These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.

EXPR

Overview Of Value Stocks In The Consumer Cyclical Sector

Canterbury Park Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPHC#NASDAQ">CPHC</a>) reported quarterly earnings of $1.07 per share. This is a 197.22 percent increase over earnings of $0.36 per share from the same period last year. The company reported $16.34 million in sales this quarter. This is a 8.06 percent decrease over sales of $17.77 million the same period last year.

Canterbury Park Holding Q2 EPS $1.07 Up From $0.36 YoY, Sales $16.34M Down From $17.77M YoY

Canterbury Park Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPHC#NASDAQ">CPHC</a>) reported quarterly earnings of $0.22 per share. This is a 83.94 percent decrease over earnings of $1.37 per share from the same period last year. The company reported $13.12 million in sales this quarter. This is a 5.99 percent decrease over sales of $13.96 million the same period last year.

Canterbury Park Holding Q4 EPS $0.22 Down From $1.37 YoY, Sales $13.12M Down From $13.96M YoY

Canterbury Park Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPHC#NASDAQ">CPHC</a>) reported quarterly earnings of $0.60 per share. This is a 3.45 percent increase over earnings of $0.58 per share from the same period last year. The company reported $22.29 million in sales this quarter. This is a 4.43 percent increase over sales of $21.35 million the same period last year.

Canterbury Park Holding Q3 EPS $0.60 Up From $0.58 YoY, Sales $22.29M Up From $21.35M YoY

Canterbury Park Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPHC#NASDAQ">CPHC</a>) reported quarterly earnings of $0.36 per share. This is a 7.69 percent decrease over earnings of $0.39 per share from the same period last year. The company reported $17.77 million in sales this quarter. This is a 11.98 percent increase over sales of $15.87 million the same period last year.

Canterbury Park Holding Q2 EPS $0.36 Down From $0.39 YoY, Sales $17.77M Up From $15.87M YoY

<h3>Gainers</h3>
<ul>
<li>Eos Energy Enterprises, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eose#NASDAQ">EOSE</a>) shares gained 41.8% to settle at $1.90 on Tuesday. Eos Energy Enterprises recently reported worse-than-expected Q1 EPS and sales results.</li>
<li>FlexShopper, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fpay#NASDAQ">FPAY</a>) rose 36.9% to settle at $1.24. FlexShopper recently posted a Q1 loss of $0.14 per share.</li>
<li>Talaris Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tals#NASDAQ">TALS</a>) gained 35.9% to close at $8.89. Talaris Therapeutics recently reported quarterly losses of $0.45 per share.</li>
<li>Redbox Entertainment Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdbx#NASDAQ">RDBX</a>) jumped 35.8% to close at $3.91. Chicken Soup For The Soul Entertainment recently agreed to acquire entertainment company Redbox Entertainment.</li>
<li>Mmtec, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtc#NASDAQ">MTC</a>) gained 35.8% to settle at $0.43.</li>
<li>Enthusiast Gaming Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eglx#NASDAQ">EGLX</a>) rose 35.2% to settle at $2.46. Enthusiast Gaming recently reported quarterly losses of $0.08 per share.</li>
<li>Biomea Fusion, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bmea#NASDAQ">BMEA</a>) climbed 34.5% to close at $5.22 on Tuesday. Biomea Fusion posted a Q1 of $0.56 per share.</li>
<li>Nisun International Enterprise Development Group Co., Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nisn#NASDAQ">NISN</a>) gained 32.7% to close at $0.8131 after the company reported FY21 EPS and sales results were higher year over year.</li>
<li>Jumia Technologies AG (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jmia#NASDAQ">JMIA</a>) climbed 30.9% to close at $7.24. Jumia Technologies reported first-quarter FY22 revenue growth of 44.3% year-on-year to $47.6 million.</li>
<li>Verb Technology Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/verb#NASDAQ">VERB</a>) jumped 29.8% to settle at $0.4256.</li>
<li>Molecular Data Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mkd#NASDAQ">MKD</a>) gained 29.7% to settle at $0.15.</li>
<li>Nutex Health, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nutx#NASDAQ">NUTX</a>) jumped 28.3% to close at $7.49.</li>
<li>Sunlight Financial Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sunl#NYSE">SUNL</a>) rose 27.9% to settle at $4.40 following Q1 results.</li>
<li>Marpai, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrai#NASDAQ">MRAI</a>) gained 27.6% to settle at $1.34.</li>
<li>Yellow Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/yell#NASDAQ">YELL</a>) jumped 26.3% to close at $4.32. Yellow recently reported worse-than-expected Q1 EPS and sales results.</li>
<li>BTCS Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/btcs#NASDAQ">BTCS</a>) climbed 26% to close at $3.05. BTCS reported first-quarter FY22 revenue growth of 776% year-on-year to $0.6 million.</li>
<li>The Valens Company Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vlns#NASDAQ">VLNS</a>) rose 25.7% to close at $0.88. The company recently raised FY22 sales guidance.</li>
<li>Guardforce AI Co., Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gfai#NASDAQ">GFAI</a>) jumped 25.7% to settle at $0.60.</li>
<li>Forge Global Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/frge#NYSE">FRGE</a>) rose 25.1% to close at $21.88 after the company reported Q1 earnings results.</li>
<li>Applied UV, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/auvi#NASDAQ">AUVI</a>) gained 25% to settle at $1.30. Applied UV announced Inclusion in a multi-million dollar contract offering throughout non-public schools in the State of Washington.</li>
<li>Chicken Soup for the Soul Entertainment, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/csse#NASDAQ">CSSE</a>) jumped 24.2% to close at $6.36 on Tuesday. Guggenheim reinstated Chicken Soup for the Soul with a Buy and announced a $21 price target.</li>
<li>Upstart Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/upst#NASDAQ">UPST</a>) gained 23.5% to settle at $46.66.</li>
<li>Rain Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rain#NASDAQ">RAIN</a>) rose 23% to close at $2.83. Rain Therapeutics recently posted a Q1 loss of $0.66 per share.</li>
<li>Q2 Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qtwo#NASDAQ">QTWO</a>) jumped 22% to close at $51.36. Q2 Holdings explored options, including a sale after receiving takeover interest, Bloomberg reported.</li>
<li>Phathom Pharmaceuticals Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phat#NASDAQ">PHAT</a>) gained 21.5% to settle at $9.95. Phathom Pharmaceuticals recently reported Q1 EPS results down from last year.</li>
<li>My Size, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mysz#NASDAQ">MYSZ</a>) gained 21.4% to close at $0.2640.</li>
<li>Infinity Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/infi#NASDAQ">INFI</a>) gained 21.3% to settle at $0.68.</li>
<li>Histogen Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hsto#NASDAQ">HSTO</a>) gained 21.3% to close at $0.19. The company recently posted upbeat quarterly earnings.</li>
<li>Iris Energy Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iren#NASDAQ">IREN</a>) rose 20.8% to close at $5.92. Iris Energy named Belinda Nucifora as CFO.</li>
<li>Harpoon Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/harp#NASDAQ">HARP</a>) climbed 20.3% to close at $2.84. Wedbush recently upgraded the stock from Neutral to Outperform and raised its price target from $5 to $7.</li>
<li>LogicMark Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lgmk#NASDAQ">LGMK</a>) surged 20.2% to settle at $1.37. LogicMark recently posted a Q1 loss of $0.14 per share.</li>
<li>Terran Orbital Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/llap#NASDAQ">LLAP</a>) gained 20.2% to close at $4.52.</li>
<li>Terran Orbital recently posted a Q1 loss of $0.85 per share.</li>
<li>Vuzix Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vuzi#NASDAQ">VUZI</a>) gained 20.1% to close at $5.92. Vuzix recently reported worse-than-expected Q1 EPS results.</li>
<li>Silver Spike Investment Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ssic#NASDAQ">SSIC</a>) gained 20% to settle at $11.59.</li>
<li>electroCore, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ecor#NASDAQ">ECOR</a>) gained 19.9% to close at $0.40.</li>
<li>GT Biopharma Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gtbp#NASDAQ">GTBP</a>) climbed 19.9% to settle at $2.47. GT Biopharma reported a Q1 loss of $0.17 per share.</li>
<li>Federated National Holding Co (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fnhc#NASDAQ">FNHC</a>) gained 19.2% to close at $0.41.</li>
<li>Microvast Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mvst#NASDAQ">MVST</a>) climbed 19.1% to close at $4.00 after the company reported Q1 financial results.</li>
<li>Moving iMage Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mitq#NYSE">MITQ</a>) gained 18.3% to settle at $1.23 after the company reported Q3 sales results up from last year and raised its FY22 sales guidance.</li>
<li>Blue Water Vaccines, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bwv#NASDAQ">BWV</a>) climbed 17.8% to close at $4.83.</li>
<li>Global-e Online Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/glbe#NASDAQ">GLBE</a>) jumped 17.7% to close at $22.57 following Q1 results.</li>
<li>IonQ, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ionq#NYSE">IONQ</a>) climbed 17.5% to close at $5.71 after reporting upbeat quarterly results.</li>
<li>Janus International Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jbi#NYSE">JBI</a>) gained 16.8% to close at $10.56 after the company reported better-than-expected Q1 EPS and sales results.</li>
<li>Scholar Rock Holding Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srrk#NASDAQ">SRRK</a>) shares rose 15% to close at $5.99 after the company posted a narrower Q1 loss.</li>
<li>PLBY Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plby#NASDAQ">PLBY</a>) climbed 14.5% to settle at $9.93. PLBY Group Board of Directors has authorized a $50 million common stock repurchase program after securing financing through a private placement of preferred stock.</li>
<li>Custom Truck One Source, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ctos#NYSE">CTOS</a>) rose 13.6% to settle at $6.51.</li>
<li>Pioneer Power Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ppsi#NASDAQ">PPSI</a>) rose 13.4% to close at $3.65 after the company reported better-than-expected Q1 sales results.</li>
<li>Stratasys Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ssys#NASDAQ">SSYS</a>) gained 12.7% to close at $19.30 after the company reported better-than-expected Q1 EPS and sales results.</li>
<li>Eve Holding, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/evex#NYSE">EVEX</a>) rose 11.8% to close at $8.53.</li>
<li>Kopin Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kopn#NASDAQ">KOPN</a>) gained 11.3% to close at $1.38. Kopin received an additional $4.8 million order for the F-35 Joint Strike Fighter Program.</li>
<li>Shoals Technologies Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/shls#NASDAQ">SHLS</a>) gained 10.7% to settle at $13.42 following Q1 results.</li>
<li>LSB Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lxu#NYSE">LXU</a>) rose 10.4% to close at $21.90. LSB Industries reported stock repurchase program authorization of up to $50 million.</li>
</ul>

Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>.
<h3>Losers</h3>
<ul>
<li>AutoWeb, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/auto#NASDAQ">AUTO</a>) shares tumbled 65.4% to close at $0.79 on Tuesday after the company reported worse-than-expected Q1 EPS results and announced the creation of a special committee of the board of directors to explore strategic alternatives.</li>
<li>Enjoy Technology Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/enjy#NASDAQ">ENJY</a>) dipped 52.8% to close at $0.35 on Tuesday after the company reported worse-than-expected Q1 EPS and sales results.</li>
<li>Imperial Petroleum Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/impp#NASDAQ">IMPP</a>) shares dipped 34.6% to close at $0.50 after the company reported pricing of $40 million underwritten public offering.</li>
<li>AN2 Therapeutics Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/antx#NASDAQ">ANTX</a>) fell 30.9% to settle at $12.74.</li>
<li>Embark Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/embk#NASDAQ">EMBK</a>) fell 30.6% to close at $1.59.</li>
<li>PolarityTE, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pte#NASDAQ">PTE</a>) fell 30.4% to settle at $2.97 after the company announced a 1-for-25 reverse stock split.</li>
<li>Aprea Therapeutics Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apre#NASDAQ">APRE</a>) fell 29.7% to settle at $0.68. Aprea Therapeutics posted a Q1 loss of $0.36 per share.</li>
<li>Nerdy, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nrdy#NYSE">NRDY</a>) declined 24.9% to close at $1.93 following Q1 results.</li>
<li>GreenBox POS (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gbox#NASDAQ">GBOX</a>) fell 24.2% to close at $2.00 after the company reported Q1 earnings results.</li>
<li>Very Good Food Company Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vgfc#NASDAQ">VGFC</a>) fell 24.2% to close at $0.19.</li>
<li>Tonix Pharmaceuticals Holding Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tnxp#NASDAQ">TNXP</a>) dropped 23.6% to close at $2.21. Tonix Pharmaceuticals announced a 1-for-32 reverse stock split.</li>
<li>Sobr Safe Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sobr#NASDAQ">SOBR</a>) fell 23.4% to close at $1.53.</li>
<li>Orgenesis Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/orgs#NASDAQ">ORGS</a>) declined 21.8% to close at $2.12.</li>
<li>Albireo Pharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/albo#NASDAQ">ALBO</a>) fell 18.4% to close at $22.89 after the company reported downbeat Q1 results.</li>
<li>Benson Hill, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bhil#NASDAQ">BHIL</a>) fell 18.3% to close at $2.99.</li>
<li>Clarus Therapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crxt#NASDAQ">CRXT</a>) fell 16% to close at $0.45 after the company reported worse-than-expected Q1 EPS and sales results.</li>
<li>Creative Realities, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crex#NASDAQ">CREX</a>) fell 15.3% to close at $0.72 following Q1 results.</li>
<li>Assure Holdings Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ionm#NASDAQ">IONM</a>) fell 15.3% to settle at $2.55. Assure Hldgs posted a Q1 loss of $0.19 per share.</li>
<li>HighPeak Energy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hpk#NASDAQ">HPK</a>) fell 14.7% to close at $27.98 after the company reported Q1 EPS results were down year over year and worse-than-expected Q1 sales results.</li>
<li>Canterbury Park Holding Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cphc#NASDAQ">CPHC</a>) fell 14.75 to settle at $24.22.</li>
<li>TherapeuticsMD, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/txmd#NASDAQ">TXMD</a>) fell 14% to settle at $2.70 following a Q1 loss.</li>
<li>Locafy Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lcfy#NASDAQ">LCFY</a>) fell 13.3% to close at $0.98.</li>
<li>Valens Semiconductor Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vln#NYSE">VLN</a>) fell 12.4% to close at $3.25. Valens Semiconductor recently posted Q1 adjusted loss of $0.02 per share.</li>
<li>Walmart Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wmt#NYSE">WMT</a>) fell 11.4% to close at $131.35 after the company reported mixed financial results and lowered earnings guidance.</li>
<li>Trevena, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trvn#NASDAQ">TRVN</a>) shares fell 9.6% to close at $0.27 after gaining 49% on Monday.</li>
<li>Okyo Pharma Ltd. ADR (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/okyo#NASDAQ">OKYO</a>) shares fell 9.5% to close at $3.62 as the company priced its IPO at $4 per ADS.</li>
<li>Gogoro Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ggr#NASDAQ">GGR</a>) dropped 8.6% to close at $5.29. Gogoro recently posted Q1 sales of $94.50 million.</li>
<li>Data Storage Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dtst#NASDAQ">DTST</a>) fell 7.3% to close at $3.20. Data Storage, on Monday, reported better-than-expected Q1 financial results.</li>
<li>Edible Garden AG Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/edbl#NASDAQ">EDBL</a>) fell 6.9% to close at $1.88.</li>
</ul>

Pre-Market Outlook

ALBO

ANTX

APRE

AUTO

AUVI

BHIL

BMEA

BTCS

CREX

CRXT

CSSE

CTOS

DTST

ECOR

EDBL

EGLX

EMBK

ENJY

EOSE

EVEX

FNHC

FPAY

FRGE

GBOX

GFAI

GLBE

GTBP

HARP

HSTO

IMPP

INFI

IONM

IONQ

IREN

JMIA

KOPN

LCFY

LGMK

LLAP

MITQ

MRAI

MVST

MYSZ

NISN

NRDY

NUTX

OKYO

ORGS

PHAT

PLBY

PPSI

QTWO

RAIN

RDBX

SHLS

SOBR

SRRK

SSIC

SSYS

Sunlight Financial Holdings, Inc. Class A Common Stock

SUNL

TALS

TNXP

TRVN

TXMD

UPST

VERB

VGFC

VLNS

VUZI

YELL

81 Biggest Movers From Yesterday

<h3>Gainers</h3>
<ul>
<li>Tenon Medical, Inc.&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tnon#NASDAQ">TNON</a>) rose 350% to clsoe at $22.50&nbsp;on Wednesday&nbsp;after the company priced its IPO at $5.00 per share.</li>
<li>Vivakor, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vivk#NASDAQ">VIVK</a>) shares jumped 113.5% to close at $3.65 on Wednesday after the company announced it has signed a 10-year contract with Hot Oil Transport with a potential value of up to $250 million.</li>
<li>Acutus Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/afib#NASDAQ">AFIB</a>) gained 36% to settle at $1.09 after the company announced agreements to fund strategic growth priorities.</li>
<li>Locafy Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lcfy#NASDAQ">LCFY</a>) jumped 34.2% to close at $1.57.</li>
<li>Cosmos Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cosm#NASDAQ">COSM</a>) shares gained 34% to close at $1.42 after jumping over 16% on Tuesday. Cosmos Holdings recently posted FY21 adjusted net income of $384K.</li>
<li>Tempest Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tpst#NASDAQ">TPST</a>) surged 30.1% to close at $3.07. Tempest reported a $15 million private placement financing.</li>
<li>Studio City International Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/msc#NYSE">MSC</a>) gained 29.7% to close at $5.45.</li>
<li>Canterbury Park Holding Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cphc#NASDAQ">CPHC</a>) surged 22.2% to settle at $32.92. Canterbury Park, last month, reported fourth-quarter FY21 sales growth of 128% year-on-year, to $13.95 million.</li>
<li>Bon Natural Life Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bon#NASDAQ">BON</a>) gained 18.5% to close at $4.54. Bon Natural Life recently announced plans to launch new multi-functional health supplements.</li>
<li>Elevation Oncology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/elev#NASDAQ">ELEV</a>) jumped 17.8% to close at $2.84.</li>
<li>PAVmed Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pavm#NASDAQ">PAVM</a>) gained 16.5% to settle at $1.27.</li>
<li>AppTech Payments Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apcx#NASDAQ">APCX</a>) gained 15.9% to settle at $1.68.</li>
<li>Chindata Group Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cd#NASDAQ">CD</a>) surged 15.3% to close at $5.79.</li>
<li>Medigus Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdgs#NASDAQ">MDGS</a>) gained 15.2% to close at $1.0783. Medigus&#39; ParaZero recently signed an agreement to develop custom safety solution for a leading global automotive manufacturer&#39;s drone program.</li>
<li>TradeUP Global Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tugc#NASDAQ">TUGC</a>) climbed 15.1% to settle at $10.59.</li>
<li>Atossa Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atos#NASDAQ">ATOS</a>) gained 15% to close at $1.11. Atossa Therapeutics recently announced completion of Part B of clinical study of AT-H201.</li>
<li>Direct Digital Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drct#NASDAQ">DRCT</a>) gained 15% to close at $2.53.</li>
<li>Alliance Resource Partners, L.P. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arlp#NASDAQ">ARLP</a>) jumped 14.9% to close at $18.16. Alliance Resource Partners sees net income of $0.27-$0.28 per basic and diluted limited partner unit for 2022 quarter.</li>
<li>Nutex Health, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nutx#NASDAQ">NUTX</a>) rose 13.5% to close at $8.72 after jumping 74% on Tuesday.</li>
<li>Nordic American Tankers Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nat#NYSE">NAT</a>) climbed 12.9% to settle at $2.88.</li>
<li>Ardmore Shipping Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/asc#NYSE">ASC</a>) gained 12.8% to close at $6.33.</li>
<li>Alkermes plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alks#NASDAQ">ALKS</a>) rose 11.9% to close at $30.38 following better-than-expected Q1 results.</li>
<li>Zentalis Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zntl#NASDAQ">ZNTL</a>) gained 11.8% to close at $24.41. Pfizer agreed to invest $25 million in Zentalis Pharmaceuticals via the purchase of 953,834 shares at $26.21 per share.</li>
<li>Vertiv Holdings Co (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vrt#NYSE">VRT</a>) rose 11.5% to close at $12.87 following upbeat Q1 results.</li>
<li>Mattel, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mat#NASDAQ">MAT</a>) gained 10.8% to close at $24.49 following a WSJ report suggesting the company is in talks with private-equity firms about a potential sale.</li>
<li>Repligen Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rgen#NASDAQ">RGEN</a>) shares jumped 10.5% to close at $157.51 after reporting upbeat Q1 results.</li>
<li>JinkoSolar Holding Co., Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jks#NYSE">JKS</a>) gained 9.7% to close at $55.09.</li>
<li>Digital World Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dwac#NASDAQ">DWAC</a>) rose 9.2% to close at $44.55.</li>
<li>Bilibili Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bili#NASDAQ">BILI</a>) gained 8.1% to close at $22.23.</li>
<li>Enphase Energy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/enph#NASDAQ">ENPH</a>) gained 7.7% to close at $165.71 after the company reported better-than-expected Q1 adjusted EPS and sales results and issued Q2 sales guidance above analyst estimates.</li>
<li>Visa Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/v#NYSE">V</a>) rose 6.5% to close at $214.11 following upbeat quarterly earnings.</li>
<li>Microsoft Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/msft#NASDAQ">MSFT</a>) rose 4.8% to close at $283.22 as the company reported better-than-expected results for its third quarter.</li>
</ul>
<h3>
Losers</h3>
<ul>
<li>JE Cleantech Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jcse#NASDAQ">JCSE</a>) dipped 68.4% to close at $5.12 on Wednesday.</li>
<li>Molecular Partners AG (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/moln#NASDAQ">MOLN</a>) shares fell 36.9% to close at $8.70. The company&rsquo;s collaborating partner Amgen for MP0310 (AMG 506) will return the global rights of MP0310 to Molecular Partners following a strategic pipeline review.</li>
<li>Agile Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agrx#NASDAQ">AGRX</a>) dipped 29.9% to settle at $3.14 following effectiveness of 1:40 reverse stock split.</li>
<li>Q&amp;K International Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qk#NASDAQ">QK</a>) shares fell 25.4% to close at $0.88 after jumping around 19% on Tuesday.</li>
<li>Silence Therapeutics plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sln#NASDAQ">SLN</a>) fell 23.6% to settle at $11.07.</li>
<li>NCR Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ncr#NYSE">NCR</a>) fell 23.2% to close at $28.67 after the company reported worse-than-expected Q1 EPS and sales results. The company also cut its FY22 EPS and sales guidance.</li>
<li>Evoke Pharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/evok#NASDAQ">EVOK</a>) fell 23.2% to close at $0.66. Evoke Pharma shares jumped over 118% on Tuesday as the FDA granted new drug product exclusivity to Evoke Pharma&#39;s Gimoti (metoclopramide) nasal spray to relieve symptoms associated with acute and recurrent diabetic gastroparesis in adults.</li>
<li>Salarius Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slrx#NASDAQ">SLRX</a>) dipped 22.8% to close at $0.21. Salarius Pharmaceuticals recently announced a $2.3 million registered direct offering.</li>
<li>Rani Therapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rani#NASDAQ">RANI</a>) fell 19.7% to close at $10.44. Rani Therapeutics, last month, posted a Q4 loss of $0.27 per share.</li>
<li>Diffusion Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dffn#NASDAQ">DFFN</a>) fell 18.4% to close at $5.80. Diffusion Pharmaceuticals recently company announced a 1-for-50 reverse stock split.</li>
<li>Forge Global Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/frge#NYSE">FRGE</a>) fell 18% to close at $15.13.</li>
<li>Solid Biosciences Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sldb#NASDAQ">SLDB</a>) dipped 17% to close at $0.6434. Solid Biosciences is shaving down its pipeline, updating its operations strategy to prioritize the advancement of AAV-mediated gene transfer therapies, SGT-001 and SGT-003.</li>
<li>iSpecimen Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ispc#NASDAQ">ISPC</a>) dropped 16.9% to close at $3.19.</li>
<li>Extreme Networks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/extr#NASDAQ">EXTR</a>) fell 16.8% to close at $9.40 following Q3 results.</li>
<li>ToughBuilt Industries, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tblt#NASDAQ">TBLT</a>) dipped 16.6% to settle at $12.10. ToughBuilt Industries reported a 41% online sales growth through Amazon in Q1.</li>
<li>Citius Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ctxr#NASDAQ">CTXR</a>) dropped 16.5% to close at $0.9101. Citius Pharmaceuticals enrolled first patient in Phase 2b study of Halo-lido for the prescription treatment of haemorrhoids.</li>
<li>Sono Group N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sev#NASDAQ">SEV</a>) fell 16.4% to close at $4.93 after the company reported a 10 million share follow-on offering.</li>
<li>IDEX Biometrics ASA (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/idba#NASDAQ">IDBA</a>) dipped 15.7% to close at $10.98.</li>
<li>Avenue Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atxi#NASDAQ">ATXI</a>) fell 14.9% to settle at $0.3697.</li>
<li>ION Geophysical Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/io#NYSE">IO</a>) declined 14.7% to close at $0.4945. Alliance Global Partners downgraded the stock from Buy to Sell.</li>
<li>Tian Ruixiang Holdings Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tirx#NASDAQ">TIRX</a>) dropped 14.6% to close at $0.7670.</li>
<li>F5, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ffiv#NASDAQ">FFIV</a>) fell 12.8% to close at $169.01 after the company reported Q2 earnings results and issued Q3 sales guidance below analyst estimates.</li>
<li>Spotify Technology S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/spot#NYSE">SPOT</a>) dipped 12.4% to settle at $96.67 after the company reported Q1 financial results.</li>
<li>Bright Minds Biosciences Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drug#NASDAQ">DRUG</a>) fell 9.4% to close at $1.06.</li>
<li>Diebold Nixdorf, Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dbd#NYSE">DBD</a>) dropped 8.5% to close at $4.32.</li>
<li>Hawaiian Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ha#NASDAQ">HA</a>) dropped 8.2% to close at $17.04 following Q1 results.</li>
<li>Trinity Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/trn#NYSE">TRN</a>) fell 8.1% to close at $28.15 following downbeat quarterly results.</li>
<li>Deutsche Bank Aktiengesellschaft (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/db#NYSE">DB</a>) shares fell 6.9% to close at $10.13 following Q1 earnings.</li>
<li>Capital One Financial Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cof#NYSE">COF</a>) fell 6% to settle at $124.35 after the company reported Q1 earnings results.</li>
<li>Alphabet Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/googl#NASDAQ">GOOGL</a>) fell 3.7% to close at $2,285.89 following downbeat quarterly earnings.</li>
</ul>

Comments

Canterbury Park Holding

Notizie

Ultime notizie per Canterbury Park Holding (NASDAQ:CPHC) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO